NoPrescriptionDrugstore.com Order Status FAQ Online Drugstore Affiliate Program Contact NoPrescriptionDrugstore.com No Prescription Drugs Newsletter Refer a Friend
 
Friday, May 02, 2008  
Largest Study To Date Finds ICDs Beneficial In Children, But Inappropriate Shocks Can Be A Problem (No Prescription)
Largest Study To Date Finds ICDs Beneficial In Children, But Inappropriate Shocks Can Be A Problem
More and more children with congenital heart disease are receiving implantable cardioverter-defibrillators (ICDs) to maintain proper heart rhythm. ICDs were first introduced for adults in the 1980s, but little is known about how well they work in children, who account for less than 1 percent of recipients.
Source: www.medicalnewstoday.com

Study In 7,000 Men And Women Ties Obesity, Inflammatory Proteins To Heart Failure Risk
Heart specialists at Johns Hopkins and elsewhere report what is believed to be the first wide-scale evidence linking severe overweight to prolonged inflammation of heart tissue and the subsequent damage leading to failure of the body's blood-pumping organ.
Source: www.medicalnewstoday.com

Cleaning, Home Repair Programs Fail To Reduce Lead Levels In Kids
Programs that promote household cleaning, home repairs and parental awareness of lead hazards are not effective at protecting children from exposure to this poison, according to a new review of studies.The review looked at interventions that attempted to reduce lead exposure for children and found that "none that have been tried so far have been proven to be effective," said lead author Dr.
Source: www.medicalnewstoday.com

Premature Infants Benefit From Diets Rich In Protein
More than 12 percent of babies are born prematurely, up more than 20 percent from 1990, and as premature birth rates continue to climb, neonatologists at Nationwide Children's Hospital are focusing their attention on the nutrition provided to premature infants during their first few days of life.
Source: www.medicalnewstoday.com

Proteolix Initiates Phase 2 Clinical Trial Of Carfilzomib In Patients With Relapsed Solid Tumors
Proteolix, Inc. announced that patient dosing has commenced in a Phase 2 clinical trial of carfilzomib (PR-171), a selective blocker of proteasome activity, in relapsed solid tumors. A Phase 1b dose-escalation trial of carfilzomib in patients with advanced solid tumors has recently been completed.
Source: www.medicalnewstoday.com

Making It Easier To Talk About Mental Health
With data suggesting that one in five Illinois residents is experiencing a mental health challenge at any one time, a new public education campaign was launched to promote good mental health and to empower those living with a mental health issue to Say it out loud.
Source: www.medicalnewstoday.com

US Oncology Applauds Journal Of Clinical Oncology Study Highlighting Value Of PET Scans For Cancer Patients With Various Types Of Malignancies
US Oncology, which supports one of the nation's largest cancer treatment and research networks representing approximately 1,200 oncologists nationwide, applauded a national study appearing in today's Journal of Clinical Oncology (JCO) that demonstrates the value of positron emission tomograp
Source: www.medicalnewstoday.com

Labels: ,


Subscribe to Posts [Atom]

Home | Order Status | FAQ | Affiliates | Contact us | Newsletter | Refer a Friend

© 2004 Online Pharmacy. All Rights Reserved.